Company Filing History:
1 out of 550 
1 out of 3,539 
Years Active: 2018
Title: Irini Sereti: Innovator in Cancer Treatment
Introduction
Irini Sereti is a prominent inventor based in Washington, DC, known for her significant contributions to the field of cancer treatment. She has developed innovative methods aimed at improving the management of Kaposi's sarcoma and KSHV-induced lymphoma. Her work focuses on utilizing immunomodulatory compounds to enhance patient outcomes.
Latest Patents
Irini Sereti holds a patent titled "Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers." This patent outlines the use of gene and protein biomarkers as predictors of clinical sensitivity in patients suffering from Kaposi's sarcoma or KSHV-induced lymphoma. It also details methods for treating these conditions with immunomodulatory compounds, either alone or in combination with doxorubicin.
Career Highlights
Throughout her career, Irini has worked with notable organizations such as Celgene Corporation and the National Institutes of Health, which is a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to contribute significantly to cancer research and treatment methodologies.
Collaborations
Irini has collaborated with esteemed colleagues, including Robert Yarchoan and Jerome B. Zeldis. These partnerships have furthered her research and development efforts in the field of oncology.
Conclusion
Irini Sereti's innovative work in cancer treatment exemplifies her dedication to improving patient care through scientific advancements. Her contributions continue to influence the landscape of cancer research and therapy.